argenx 股票：調升至「買入」評級，VYVGART 增長週期仍有後勁 (NASDAQ:ARGX)
· seekingalpha.com
將 argenx (ARGX) 調升至「買入」評級，目標價 1,050 美元：VYVGART 增長、適應症拓展、強勁利潤率及管線潛力。點擊查看更多細節。
Lifescience investor focused on non-consensus long-short investment ideas. I focus on small to mid-cap biotechnology companies that are public on the US and EU ...